F. Hoffmann-La Roche Ltd: CHMP recommends EU approval of Roche's Gazyva/Gazyvaro for lupus nephritis

Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro's superiority over standard therapy alone1,2 Gazyva/Gazyvaro is the only anti-CD20 antibody to ...
Le Lézard

TEZSPIRE approved in the US for chronic rhinosinusitis with nasal polyps

AstraZeneca and Amgen's TEZSPIRE® (tezepelumab -ekko) has been approved in the US for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with inadequately ...